[ad_1] PISCATAWAY, N.J., Sept. 12, 2024 /PRNewswire/ — GenScript Biotech Corporation (“GenScript”), a global leader in life sciences products and services, announced the appointment of Dr. Ross Allen Grossman as a Non-Executive Director and Dr. […]
Tag: Medical Pharmaceuticals
Kedrion Biopharma’s Focus on Advancing Patient Care in Rare Disease to be Showcased at NBDF Conference 2024
[ad_1] ATLANTA, Sept. 11, 2024 /PRNewswire/ — Kedrion Biopharma Inc. is excited to announce its sponsorship of the National Bleeding Disorders Foundation’s (NBDF) 76th Annual Bleeding Disorders Conference (BDC) in Atlanta, Georgia. The event will […]
BIOVAXYS ANNOUNCES CLOSING OF THIRD TRANCHE OF PRIVATE PLACEMENT
[ad_1] // NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, Sept. 11, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (“BioVaxys” or the […]
Innovent’s Phase 3 Clinical Trial DREAMS-2 of Mazdutide in Chinese Patients with Type 2 Diabetes were Orally Presented at EASD 2024
[ad_1] SAN FRANCISCO and SUZHOU, China, Sept. 11, 2024 /PRNewswire/ — Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular […]
TREMFYA® (guselkumab) receives U.S. FDA approval for adults with moderately to severely active ulcerative colitis, strengthening Johnson & Johnson’s leadership in inflammatory bowel disease
[ad_1] The first and only dual-acting interleukin-23 inhibitor approved in active ulcerative colitis, TREMFYA® showed highly statistically significant rates of endoscopic remission at one year in the pivotal QUASAR program1,2,3,4,5 TREMFYA® is now approved for the treatment […]
